RO7428731
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7428731, covering 2025-05-22 to 2025-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma [Phase 1]